Navigation Links
Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
Date:5/7/2008

210

Net income (loss) $(2,326) $1,674

Net income (loss) per share - basic $(0.05) $0.04

Net income (loss) per share - diluted $(0.05) $0.04

Weighted-average shares outstanding - basic 47,030 37,964

Weighted-average shares outstanding - diluted 47,030 41,685

VOLCANO CORPORATION

RECONCILIATION OF GAAP AND NON-GAAP OPERATING RESULTS

(in thousands, except per share data)

(Unaudited)

Three Months Ended March 31, 2008

In-process Acquisition

Stock-based research due

GAAP compensation and diligence Non-GAAP

results expense development costs results

Revenues $36,647 $- $- $- $36,647

Cost of revenues 13,629 (191) - - 13,438

Gross profit 23,018 191 - - 23,209

Operating expenses:

Selling, general

and

administrative 22,059 (1,501) - (2,878) 17,680

Research and

development 5,637 (369) - - 5,268

In-process

research and

development 175 - (175) - -

Amortization of

intangibles 773 - - - 773

Total operating

expenses 28,644 (1,870) (175) (2,878) 23,721

Operating loss (5,626) 2,061 175 2,878 (512)

Interest income 1,833 - - - 1,833<
'/>"/>

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
2. Volcano Corporation Announces Pricing of Common Stock Offering
3. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
4. Volcano Announces Closing of CardioSpectra Acquisition
5. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
6. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
7. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
8. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. QMed, Inc. Reports July Medicare SNP Enrollments
11. Phlo Affiliate Reports Expanded Coverage to Oregon Border
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... rarely simple. From crop yields to disease risks, the ... considered "complex traits." Just as for heightthe textbook example ... human disease are shaped by multiple genetic and environmental ... To track down such genes, geneticists typically mate two ... mouse and a small mouseand then study their descendents, ...
(Date:9/19/2014)... 2014 Follow us on ... revolutionize the world has attracted diverse players including ... start-ups. The early years of nanotechnology development was ... to the high risks involved, which deterred private ... this evolving technology have been growing over the ...
(Date:9/19/2014)... Sept. 19, 2014  Nektar Therapeutics (NASDAQ: ... studies characterizing the analgesic profiles of a series ... receptor agonist molecules. The preclinical research candidates were ... platform. The analgesic properties of kappa ... literature. 1,2 Kappa opioid receptors are expressed ...
(Date:9/19/2014)... 2014 Barnhardt Manufacturing Company ... its Organic Cotton . The USDA Certified Biobased ... biobased ingredients meets or exceeds levels set by USDA. ... whole or in significant part of agricultural, forestry, or ... Organic cotton to be immediately identified as a USDA ...
Breaking Biology Technology:Want to link genes to complex traits? Start with more diversity 2Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Barnhardt Manufacturing Company Earns USDA Certified Biobased Product Certification and Label for Organic Cotton 2
... WILMINGTON, Del., Sept. 25 The results ... Proof Of Concept) Study of ZD4054 -- a ... today at the 14th European Congress,of Clinical Oncology ... ZD4054, an investigational compound in development for the,treatment ...
... MDVN ) today announced that it has been ... new NASDAQ(R) NeuroInsights(R) Neurotech Index.,The Index launched today and ... a total return basis (Nasdaq: NRVX.) "Medivation,s selection ... industry is testament to our commitment to and significant,clinical ...
... FRANCISCO, Sept. 25 BioSpace, the leading online,source ... the 2008 BIO,International Convention and BIOCOM, unveiled this ... Campaign. The campaign features both a,regional promotional Hotbed ... with the economic and workforce development initiatives of,Southern ...
Cached Biology Technology:Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients 2Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients 3Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients 4Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index 2Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index 3BioSpace, 2008 BIO International Convention and BIOCOM Launch 9th Edition of Biotech Beach Hotbed Map Campaign 2
(Date:9/21/2014)... newborn immune T cells may have the ability to ... new study led by King,s College London. Although their ... babies may still be able to mount a strong ... Nature Medicine . , Our immune system is ... including neutrophils which play an important role in the ...
(Date:9/19/2014)... will study the unique bioelectric signaling system of the ... health. The OU researcher is working to understand ... the signals used to map the world around them. ... of 500-600 discharges a second throughout their lives. ... extreme, but necessary for survival. , "There is evidence ...
(Date:9/19/2014)... legume plants regulate their symbiotic relationship with soil ... through the plant structure from leaves into the ... in the roots. This collaborative study was conducted ... Biology, the Graduate University for Advanced Studies (SOKENDAI), ... in Japan. , Legumes, an important plant ...
Breaking Biology News(10 mins):Immune system of newborn babies is stronger than previously thought 2For legume plants, a new route from shoot to root 2
... seeps are deep-sea environments, usually a few square meters ... from the sea floor. Mud volcanoes which are active ... in the 1990s. These harsh conditions give rise to ... for life to exist on the planet. , ...
... protein crucial for the growth of brain cells during ... of long-term memories, according to researchers at UC Irvine. ... and treatments for, cognitive decline associated with normal aging ... appear in the early online edition of the Proceedings ...
... turning on a single gene, researchers can prevent skin stem ... cells -- epidermal, sebaceous and hair cells. They say this ... stem cells in the lab, for both research and potential ... which have the ability to differentiate into multiple types of ...
Cached Biology News:Life in the extreme 2Proteins necessary for brain development found to be critical for long-term memory 2Researchers identify a key regulator for skin stem cells 2
Carrier Serum...
A Highly Purified, Cost-Effective Taq DNA Polymerase...
Homo sapiens similar to Cytosolic acyl coenzyme A thioester hydrolase Antigen: Peptide...
... is a protein based inhibitor of nonhuman ... most common and troublesome RNases including RNase ... can be used in any application where ... ideal for in vitro transcription and translation, ...
Biology Products: